A month later, Dr. Belldegrun formed Kite with a group of colleagues and investors to pursue cancer immunotherapy. That same month, a Florida marine contractor named Eric Karlson, whose  ’s lymphoma was advancing despite four prior treatments, became the first patient treated by Dr. Rosenberg with what would eventually become  . The treatment entailed removing some of Mr. Karlson’s immune system T cells from his blood, genetically engineering them to recognize and fight his cancer, multiplying the T cells to huge numbers in the laboratory and transferring them back into his body. After two such treatments, Mr. Karlson remains alive and   eight years later. 